Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice

Eur J Neurosci. 2002 Mar;15(5):841-51. doi: 10.1046/j.1460-9568.2002.01917.x.

Abstract

Genetic deficiency of monoamine oxidase-A (MAO-A) induces major alterations of mood and behaviour in human. Because serotonin (5-HT) is involved in mood regulation, and MAO-A is responsible for the catabolism of 5-HT, we investigated 5-HT mechanisms in knock-out mice (2-month-old) lacking MAO-A, using microdialysis, electrophysiological, autoradiographic and molecular biology approaches. Compared to paired wild-type mice, basal extracellular 5-HT levels were increased in ventral hippocampus (+202%), frontal cortex (+96%) and dorsal raphe nucleus (DRN, +147%) of MAO-A mutant mice. Conversely, spontaneous firing rate of 5-HT neurons in the DRN (recorded under chloral hydrate anaesthesia) was approximately 40% lower in mutants. Acute 5-HT reuptake blockade by citalopram (0.2 and 0.8 mg/kg i.v.) produced a much larger increase in extracellular 5-HT levels (by approximately 4 fold) and decrease in DRN neuronal firing (with a approximately 4.5 fold decrease in the drug's ED50) in MAO-A knock-out mice, which expressed lower levels of the 5-HT transporter throughout the brain (-13 to -34% compared to wild-type levels). The potency of the 5-HT1A agonist 8-OH-DPAT to produce hypothermia and to reduce the firing of DRN serotoninergic neurons was significantly less in the mutants, indicating a desensitization of 5-HT1A autoreceptors. This was associated with a decreased autoradiographic labelling of these receptors (-27%) in the DRN. Altogether, these data indicate that, in MAO-A knock-out mice, the enhancement of extracellular 5-HT levels induces a down-regulation of the 5-HT transporter, and a desensitization of 5-HT1A autoreceptors which allows the maintenance of tonic activity of 5-HT neurons in the DRN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Animals
  • Autoreceptors / antagonists & inhibitors
  • Autoreceptors / metabolism*
  • Brain / enzymology*
  • Brain / physiopathology
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Citalopram / pharmacology
  • Down-Regulation / genetics
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Female
  • Hydroxyindoleacetic Acid / metabolism
  • Male
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism*
  • Membrane Transport Proteins*
  • Mice
  • Mice, Knockout
  • Monoamine Oxidase / deficiency*
  • Monoamine Oxidase / genetics
  • Nerve Tissue Proteins*
  • Neurons / enzymology*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Raphe Nuclei / drug effects
  • Raphe Nuclei / metabolism
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin / genetics
  • Receptors, Serotonin / metabolism*
  • Receptors, Serotonin, 5-HT1
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Serotonin / metabolism*
  • Serotonin Antagonists / pharmacology
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Receptor Agonists / pharmacology
  • Tritium

Substances

  • Autoreceptors
  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Receptors, Serotonin
  • Receptors, Serotonin, 5-HT1
  • Serotonin Antagonists
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Receptor Agonists
  • Serotonin Uptake Inhibitors
  • Slc6a4 protein, mouse
  • Citalopram
  • Tritium
  • Serotonin
  • Hydroxyindoleacetic Acid
  • Monoamine Oxidase